Nordea Investment Management Ab Ligand Pharmaceuticals Inc Transaction History
Nordea Investment Management Ab
- $103 Billion
- Q2 2025
A detailed history of Nordea Investment Management Ab transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 58,660 shares of LGND stock, worth $8.96 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,660
Previous 58,632
0.05%
Holding current value
$8.96 Million
Previous $6.16 Million
8.18%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding LGND
# of Institutions
289Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$319 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$162 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$141 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$114 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.58B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...